Suchergebnisse - (Person:"Xu, Tianmin")

PubPharm (11)

1

New insights about endometriosis-associated ovarian cancer : pathogenesis, risk factors, prediction and diagnosis and treatment

enthalten in: Frontiers in oncology | 2024

von Chen, B. | Zhao, L. | Yang, R. | +1

2

The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer

enthalten in: Frontiers in genetics | 2023

von Chen, B. | Zhao, L. | Yang, R. | +1

3

The HIPPO pathway in gynecological malignancies

enthalten in: American journal of cancer research | 2020

von Wang, D. | He, J. | Dong, J. | +2

4

LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p

enthalten in: Journal of cellular physiology | 2019

von Chen, J. | Lin, Y. | Jia, Y. | +3

RetractionIn: J Cell Physiol. 2023 Feb;238(2):480. - PMID 36812136

5

Macrophage Polarization in the Development and Progression of Ovarian Cancers : An Overview

enthalten in: Frontiers in oncology | 2019

von Cheng, H. | Wang, Z. | Fu, L. | +1

6

Are ovarian cancer stem cells the target for innovative immunotherapy?

enthalten in: OncoTargets and therapy | 2018

von Wang, L. | Xu, T. | Cui, M.

7

MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1

enthalten in: Oncotarget | 2017

von Lin, Y. | Xu, T. | Zhou, S. | +1

RetractionIn: Oncotarget. 2023 Jun 12;14:579. - PMID 37306518

8

Establishment of specific cytotoxic T lymphocyte culture system and its inhibitory effect on ovarian cancer

enthalten in: Oncology letters | 2016

von Sui, M. | Si, L. | Xu, T. | +1

9

Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P. pastoris

enthalten in: Oncology reports | 2016

von CHANG, W. | XU, T. | ZHANG, K. | +3

10

Expression and anticancer activity analysis of recombinant human uPA1-43-melittin

enthalten in: International journal of oncology | 2015

von SU, M. | CHANG, W. | CUI, M. | +3